Comparable stake leader
Meeshanthini Dogan
SEC ownership of Cardio Diagnostics Holdings, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001870144.
Disclosed value leader
Meeshanthini Dogan
Comparable rows
0/37
Latest evidence
30 Jun 2026
- Public ticker
- CDIO, CDIOW on Nasdaq
- Parsed ownership sources
-
3/4/5 and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Meeshanthini Dogan
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001870144
- Issuer location
- Chicago, IL
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Cardio Diagnostics Holdings, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Meeshanthini Dogan
Disclosed value leader
Meeshanthini Dogan
Comparable rows
0/37
Latest evidence
30 Jun 2026
3/4/5
13F
Highest disclosed value: $4,424,560
37 rows are not safely comparable across share classes.
Showing 1-8 of 37 holder rows.
Quick read
Meeshanthini Dogan has the largest disclosed position value at $4.42M.
0 of 37 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Meeshanthini Dogan's linked filing trail.
Disclosed position value
Top 5
Meeshanthini Dogan
$4.42M
Timur Dogan
$4M
Robert Philibert
$2.18M
Warren Hosseinion
$1.06M
Khullani Abdullahi
$641.7K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 37 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Meeshanthini Dogan |
3/4/5
Chief Executive Officer, Director
|
—
mixed-class rows
|
$4,424,560
3,524,854 shares
mixed-class rows
|
— | 06 Sep 2024 |
| Timur Dogan |
3/4/5
Chief Technology Officer
|
—
mixed-class rows
|
$4,001,706
2,066,735 shares
mixed-class rows
|
— | 06 Sep 2024 |
| Robert Philibert |
3/4/5
Chief Medical Officer, Director
|
—
mixed-class rows
|
$2,179,096
2,489,332 shares
mixed-class rows
|
— | 06 Sep 2024 |
| Warren Hosseinion |
3/4/5
Director
|
—
class O/S missing
|
$1,059,631
502,195 shares
|
— | 23 Jan 2024 |
| Khullani Abdullahi |
3/4/5
VP of Revenue and Strategy
|
—
class O/S missing
|
$641,710
304,128 shares
|
— | 23 Jan 2024 |
| Elisa Luqman V |
3/4/5
Chief Financial Officer
|
—
class O/S missing
|
$558,796
264,832 shares
|
— | 23 Jan 2024 |
| Brandon Sim |
3/4/5
Director
|
—
class O/S missing
|
$156,355
62,793 shares
|
— | 31 Dec 2023 |
| Stanley K. Lau |
3/4/5
Director
|
—
mixed-class rows
|
$152,405
134,161 shares
mixed-class rows
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 28 Sep 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-17 of 17 reporting-owner rows connected to Cardio Diagnostics Holdings, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
17
Largest Forms 3/4/5 holder
Meeshanthini Dogan
Net 12M change
$0
Latest report
30 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Meeshanthini Dogan | Chief Executive Officer, Director | $4,424,560 | Mixed | 06 Sep 2024 | ||
| Timur Dogan | Chief Technology Officer | $4,001,706 | Mixed | 06 Sep 2024 | ||
| Robert Philibert | Chief Medical Officer, Director | $2,179,096 | Mixed | 06 Sep 2024 | ||
| Warren Hosseinion | Director | $1,059,631 | Mixed | 23 Jan 2024 | ||
| Khullani Abdullahi | VP of Revenue and Strategy | $641,710 | Mixed | 23 Jan 2024 | ||
| Elisa Luqman V | Chief Financial Officer | $558,796 | Mixed | 23 Jan 2024 | ||
| Brandon Sim | Director | $156,355 | Mixed | 31 Dec 2023 | ||
| Stanley K. Lau | Director | $152,405 | Mixed | 30 Sep 2024 | ||
| Oded Levy | Director | $111,609 | Mixed | 30 Sep 2024 | ||
| James Intrater | Director | $19,671 | Mixed | 30 Jun 2026 | ||
| Paul Frederick Burton | Director | $19,671 | Mixed | 30 Jun 2026 | ||
| Peter K. Fung | Director | $17,094 | Mixed | 30 Jun 2026 | ||
| Wendy J. Betts | Director | $17,094 | Mixed | 30 Jun 2026 | ||
| Mana Capital LLC | 10%+ Owner | Mixed | 25 Oct 2022 | |||
| Loren Mortman | Director | Mixed | 22 Nov 2021 | |||
| Jonathan Intrater | Ceo | Mixed | 22 Nov 2021 | |||
| Allan Liu | Director | Mixed | 22 Nov 2021 |
Recent insider transactions for Cardio Diagnostics Holdings, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Peter K. Fung | CDIO | Stock Options (Right to Buy) | Award | 30% | 2,854 | 12,367 | 30 Jun 2026 | Direct | ||
| Wendy J. Betts | CDIO | Stock Options (Right to Buy) | Award | 30% | 2,854 | 12,367 | 30 Jun 2026 | Direct | ||
| James Intrater | CDIO | Stock Options (Right to Buy) | Award | 27.3% | 2,854 | 13,318 | 30 Jun 2026 | Direct | ||
| Paul Frederick Burton | CDIO | Stock Options (Right to Buy) | Award | 27.3% | 2,854 | 13,318 | 30 Jun 2026 | Direct | ||
| Peter K. Fung | CDIO | Stock Options (Right to Buy) | Award | 50.8% | 3,205 | 9,513 | 31 Mar 2026 | Direct | ||
| Wendy J. Betts | CDIO | Stock Options (Right to Buy) | Award | 50.8% | 3,205 | 9,513 | 31 Mar 2026 | Direct | ||
| James Intrater | CDIO | Stock Options (Right to Buy) | Award | 44.2% | 3,205 | 10,464 | 31 Mar 2026 | Direct | ||
| Paul Frederick Burton | CDIO | Stock Options (Right to Buy) | Award | 44.2% | 3,205 | 10,464 | 31 Mar 2026 | Direct | ||
| Peter K. Fung | CDIO | Stock Options (Right to Buy) | Award | 57.6% | 2,306 | 6,308 | 31 Dec 2025 | Direct | ||
| Wendy J. Betts | CDIO | Stock Options (Right to Buy) | Award | 57.6% | 2,306 | 6,308 | 31 Dec 2025 | Direct | ||
| James Intrater | CDIO | Stock Options (Right to Buy) | Award | 46.6% | 2,306 | 7,259 | 31 Dec 2025 | Direct | ||
| Paul Frederick Burton | CDIO | Stock Options (Right to Buy) | Award | 46.6% | 2,306 | 7,259 | 31 Dec 2025 | Direct | ||
| Peter K. Fung | CDIO | Stock Options (Right to Buy) | Award | 63.8% | 1,559 | 4,002 | 30 Sep 2025 | Direct | ||
| Wendy J. Betts | CDIO | Stock Options (Right to Buy) | Award | 63.8% | 1,559 | 4,002 | 30 Sep 2025 | Direct | ||
| James Intrater | CDIO | Stock Options (Right to Buy) | Award | 45.9% | 1,559 | 4,953 | 30 Sep 2025 | Direct | ||
| Paul Frederick Burton | CDIO | Stock Options (Right to Buy) | Award | 45.9% | 1,559 | 4,953 | 30 Sep 2025 | Direct |
* marks a reported price that did not pass the local price check.